NCT04711915View on ClinicalTrials.gov

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

July 1, 2026

Study Completion Date

December 1, 2026

Conditions
Major Depressive DisorderDepression
Interventions
DRUG

0.1 mg/kg Dimethyltryptamine (DMT)

0.1 mg/kg DMT

DRUG

0.3 mg/kg Dimethyltryptamine (DMT)

0.3 mg/kg DMT

Trial Locations (1)

06516

Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine, West Haven

All Listed Sponsors
lead

Yale University

OTHER